FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387344901> ?p ?o ?g. }

• W4387344901 abstract "Abstract Background Pain management is a major unmet need in people with rheumatoid arthritis (RA). Although many patients are treated with Disease Modifying Anti-Rheumatic Drugs (DMARDS), including biologic therapies, many people with RA continue to experience significant pain. We aimed to determine whether performing a comprehensive pain evaluation is feasible in people with active RA receiving conventional DMARDs and biologic therapies. Methods The BIORA-PAIN feasibility study was an open-label, randomised trial, which recruited participants suitable for treatment with biologic therapy. The primary feasibility outcomes were recruitment, randomisation and retention of eligible participants. All participants underwent pain assessment for nociceptive, neuropathic and nociplastic pain during the 12-month study period, with quarterly assessments for VAS (Visual Analogue Scale) pain, painDETECT and QST (Quantitative Sensory Testing). This trial was registered in clinicaltrials.gov NCT04255134. Results During the study period, 93 participants were screened of whom 25 were eligible; 13 were randomised to adalimumab and 12 to abatacept. Participant recruitment was lower than expected due to the Covid-19 pandemic. Pain assessments were practical in the clinical trial setting. An improvement was observed for VAS pain from baseline over 12 months, with a mean (SEM) of 3.7(0.82) in the abatacept group and 2.3(1.1) in the adalimumab group. There was a reduction in painDETECT and improvement in QST measures in both treatment groups during the study. Participant feedback included that some of the questionnaire-based pain assessments were lengthy and overlapped in their content. Adverse events were similar in both groups. There was one death due to Covid-19. Conclusions This first-ever feasibility study of a randomised controlled trial assessing distinct modalities of pain in RA met its progression criteria. This study demonstrates that it is feasible to assess participants with active RA for specific modalities of pain, including nociceptive, neuropathic and nociplastic elements. Our data suggests it is possible to stratify people for RA based on pain features. The differences in pain outcomes between abatacept and adalimumab treated groups warrants further investigation. Trial Registration NCT04255134, Registered on Feb 5, 2020" @default.
• W4387344901 created "2023-10-05" @default.
• W4387344901 creator A5002407243 @default.
• W4387344901 creator A5015758160 @default.
• W4387344901 creator A5062959538 @default.
• W4387344901 creator A5064108274 @default.
• W4387344901 creator A5064317590 @default.
• W4387344901 creator A5075818510 @default.
• W4387344901 creator A5088240222 @default.
• W4387344901 creator A5089536144 @default.
• W4387344901 date "2023-10-04" @default.
• W4387344901 modified "2023-10-06" @default.
• W4387344901 title "Assessing the effects of distinct biologic therapies on rheumatoid arthritis pain by nociceptive, neuropathic and nociplastic pain components: a randomised feasibility study" @default.
• W4387344901 cites W1965431554 @default.
• W4387344901 cites W1986071902 @default.
• W4387344901 cites W1987138256 @default.
• W4387344901 cites W1995633792 @default.
• W4387344901 cites W2005089167 @default.
• W4387344901 cites W2044826902 @default.
• W4387344901 cites W2064996455 @default.
• W4387344901 cites W2082494913 @default.
• W4387344901 cites W2130607817 @default.
• W4387344901 cites W2139323151 @default.
• W4387344901 cites W2143342727 @default.
• W4387344901 cites W2170036462 @default.
• W4387344901 cites W2609372936 @default.
• W4387344901 cites W2623617647 @default.
• W4387344901 cites W2810947153 @default.
• W4387344901 cites W2895890270 @default.
• W4387344901 cites W3013045025 @default.
• W4387344901 cites W3155282282 @default.
• W4387344901 cites W3162993738 @default.
• W4387344901 cites W3165802878 @default.
• W4387344901 cites W3169529874 @default.
• W4387344901 cites W3194956376 @default.
• W4387344901 cites W4225300880 @default.
• W4387344901 doi "https://doi.org/10.21203/rs.3.rs-3116239/v1" @default.
• W4387344901 hasPublicationYear "2023" @default.
• W4387344901 type Work @default.
• W4387344901 citedByCount "0" @default.
• W4387344901 crossrefType "posted-content" @default.
• W4387344901 hasAuthorship W4387344901A5002407243 @default.
• W4387344901 hasAuthorship W4387344901A5015758160 @default.
• W4387344901 hasAuthorship W4387344901A5062959538 @default.
• W4387344901 hasAuthorship W4387344901A5064108274 @default.
• W4387344901 hasAuthorship W4387344901A5064317590 @default.
• W4387344901 hasAuthorship W4387344901A5075818510 @default.
• W4387344901 hasAuthorship W4387344901A5088240222 @default.
• W4387344901 hasAuthorship W4387344901A5089536144 @default.
• W4387344901 hasBestOaLocation W43873449011 @default.
• W4387344901 hasConcept C126322002 @default.
• W4387344901 hasConcept C14184104 @default.
• W4387344901 hasConcept C168563851 @default.
• W4387344901 hasConcept C1862650 @default.
• W4387344901 hasConcept C197934379 @default.
• W4387344901 hasConcept C2777107010 @default.
• W4387344901 hasConcept C2777575956 @default.
• W4387344901 hasConcept C2779338263 @default.
• W4387344901 hasConcept C2779605438 @default.
• W4387344901 hasConcept C2780132546 @default.
• W4387344901 hasConcept C2780653079 @default.
• W4387344901 hasConcept C42219234 @default.
• W4387344901 hasConcept C535046627 @default.
• W4387344901 hasConcept C71924100 @default.
• W4387344901 hasConceptScore W4387344901C126322002 @default.
• W4387344901 hasConceptScore W4387344901C14184104 @default.
• W4387344901 hasConceptScore W4387344901C168563851 @default.
• W4387344901 hasConceptScore W4387344901C1862650 @default.
• W4387344901 hasConceptScore W4387344901C197934379 @default.
• W4387344901 hasConceptScore W4387344901C2777107010 @default.
• W4387344901 hasConceptScore W4387344901C2777575956 @default.
• W4387344901 hasConceptScore W4387344901C2779338263 @default.
• W4387344901 hasConceptScore W4387344901C2779605438 @default.
• W4387344901 hasConceptScore W4387344901C2780132546 @default.
• W4387344901 hasConceptScore W4387344901C2780653079 @default.
• W4387344901 hasConceptScore W4387344901C42219234 @default.
• W4387344901 hasConceptScore W4387344901C535046627 @default.
• W4387344901 hasConceptScore W4387344901C71924100 @default.
• W4387344901 hasLocation W43873449011 @default.
• W4387344901 hasOpenAccess W4387344901 @default.
• W4387344901 hasPrimaryLocation W43873449011 @default.
• W4387344901 hasRelatedWork W1522989284 @default.
• W4387344901 hasRelatedWork W1969918039 @default.
• W4387344901 hasRelatedWork W1977294592 @default.
• W4387344901 hasRelatedWork W2013431856 @default.
• W4387344901 hasRelatedWork W2238463541 @default.
• W4387344901 hasRelatedWork W2909909703 @default.
• W4387344901 hasRelatedWork W2933506976 @default.
• W4387344901 hasRelatedWork W2965436229 @default.
• W4387344901 hasRelatedWork W3031221604 @default.
• W4387344901 hasRelatedWork W3046231149 @default.
• W4387344901 isParatext "false" @default.
• W4387344901 isRetracted "false" @default.
• W4387344901 workType "article" @default.